Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment-Reference-Cited by-同舟云学术

Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment

Published:2021-11-29 Issue: Volume: Page:
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Wen Nuan,Zhao Na,Xu Huixian,Zhao Ying,Ma Jian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11845-021-02837-3.pdf

Reference25 articles.

1. Abraham BP, Ahmed T, Ali T (2017) Inflammatory bowel disease: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol 239:115–146

2. Flynn S, Eisenstein S (2019) Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am 99(6):1051–1062

3. Park J, Park S, Lee SA et al (2021) Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management. Korean J Intern Med 36(5):1040–1048

4. Wallace KL, Zheng LB, Kanazawa Y, Shih DQ (2014) Immunopathology of inflammatory bowel disease. World J Gastroenterol 20(1):6–21

5. Mak WY, Zhao M, Ng SC, Burisch J (2020) The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol 35(3):380–389

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linkage of serum ITIH4 with Th2 signature cytokine, inflammation, exacerbation risk and severity in childhood asthma;Biomarkers in Medicine;2024-07-16

2. Usability of serum inter-α-trypsin inhibitor heavy chain 4 as a biomarker for assessing severity and predicting functional outcome after human aneurysmal subarachnoid hemorrhage: A prospective observational cohort study at a single institution;Clinica Chimica Acta;2024-01

3. Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis;Scandinavian Journal of Clinical and Laboratory Investigation;2023-12

4. Liver microbial community and associated host transcriptome in calves with feed induced acidosis;Frontiers in Veterinary Science;2023-10-23

5. Network proteomic analysis identifies inter-alpha-trypsin inhibitor heavy chain 4 during early human Achilles tendon healing as a prognostic biomarker of good long-term outcomes;Frontiers in Immunology;2023-07-06